These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 895249)

  • 1. [Role of unspecific inhibitors of hemagglutination in the course of immunization with live and inactivated influenza viruses].
    Zgorzelska K; Semkow R
    Med Dosw Mikrobiol; 1977; 29(2):107-11. PubMed ID: 895249
    [No Abstract]   [Full Text] [Related]  

  • 2. [Research on the immunizing and antigenic properties of some viral fractions extracted from influenza viruses of type A2].
    Moisa I; Lupu R; Blaer E
    Stud Cercet Virusol; 1972; 23(2):135-40. PubMed ID: 4646493
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of antibodies to neuraminidase of A2-Hong Kong and A2-Taiwan influenza viruses after administration of different Hong Kong vaccines and after natural infection in humans.
    Závadová H
    Acta Virol; 1973 Jul; 17(4):287-92. PubMed ID: 4148207
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of preinfection and preimmunization on the serum antibody response to subsequent immunization with heterotypic influenza vaccines.
    Jennings R; Potter CW; McLaren C
    J Immunol; 1974 Dec; 113(6):1834-43. PubMed ID: 4547776
    [No Abstract]   [Full Text] [Related]  

  • 5. The protection of ferrets against influenza by immunization with a split influenza vaccine.
    Brady MI; Furminger IG
    Dev Biol Stand; 1975; 28():167-72. PubMed ID: 1126566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of resistance to influenza virus infection in animal models.
    Potter CW; McLaren C; Jennings R
    Dev Biol Stand; 1975; 28():307-18. PubMed ID: 1126574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigens (and recombinants) and immune response to avian influenza.
    Easterday BC
    Am J Vet Res; 1975 Apr; 36(4 Pt 2):503-4. PubMed ID: 1092217
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunizing effect of different cleavage products from influenza viruses].
    Lange FC
    Monatsschr Kinderheilkd (1902); 1970 Jun; 118(6):390-1. PubMed ID: 5523686
    [No Abstract]   [Full Text] [Related]  

  • 9. Recombinant influenza-virus vaccines. IV. Segregation of antigenic and some biological properties of Influenza virus neuraminidase by recombination.
    Higashihara M; Igarashi Y; Saito Y
    Kitasato Arch Exp Med; 1976 Sep; 49(3):81-91. PubMed ID: 1029759
    [No Abstract]   [Full Text] [Related]  

  • 10. Potency of influenza vaccines: mouse protection experiments in correlation to field studies in man.
    Bachmayer H; Liehl E; Schmidt G
    Dev Biol Stand; 1975; 28():336-9. PubMed ID: 1126577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of influenza viruses type A, isolated in Turin in 1973].
    Giuliani G; Novara O; Gambera L; Castelletti GC
    G Batteriol Virol Immunol; 1974; 67(7-12):209-18. PubMed ID: 4377558
    [No Abstract]   [Full Text] [Related]  

  • 12. [Research on immunization of mice with influenza virus hemagglutinins].
    Moisa L; Stoian N
    Stud Cercet Inframicrobiol; 1971; 22(3):203-7. PubMed ID: 5128531
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of tumor immunity in mice with antigens prepared from influenza and vesicular stomatitis virus grown in suspension culture of Ehrlich ascites cells.
    Häkkinen I; Halonen P
    J Natl Cancer Inst; 1971 Jun; 46(6):1161-7. PubMed ID: 4325929
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunogenicity of inactivated influenza vaccine, purified by adsorption chromatography on porous glas.
    Bresler S; Kolikov V; Katushkina N; Molodkin V; Friedman E; Zheleznova H; Malafeieva L; Peradze T; Beljakov V; Ivanov K
    Med Biol; 1975 Dec; 53(6):456-61. PubMed ID: 1214539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preparative isolation of myxovirus glycoproteins and the study of their immunogenic properties].
    Berezin VE; Zaĭdes VM; Mchedlishvili BV; Selimova LM; Kliushnik SIu
    Mol Gen Mikrobiol Virusol; 1985 Jul; (7):36-43. PubMed ID: 3025716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-ovalbumin sensitizing ability of influenza vaccines in guinea pigs.
    Weeke-Lüttmann M; Schramm-Thiel N
    Dev Biol Stand; 1977 Jun 1-3; 39():219-222. PubMed ID: 604100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of effective constituents of influenza vaccine by immunization with plasmid DNAs encoding viral proteins.
    Ze C; Kurata T; Tamura S
    Jpn J Infect Dis; 2000 Dec; 53(6):219-28. PubMed ID: 11227019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Host antigens in purified preparations of the influenza virus].
    Zhebrun AB; Polianskaia NIu; Noskov FS; Fridman EA
    Tr Inst Im Pastera; 1982; 59():70-81. PubMed ID: 7187572
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental basis of enhancing the immunogenicity of influenza B virus by genetic recombination.
    Medvedeva TE; Gordon MA; Aleksandrova GI; Smorodintsev AA
    Acta Virol; 1980 Dec; 24(6):385-90. PubMed ID: 6111198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological response of chickens, rabbits and guinea-pigs to equine influenza vaccines.
    Frerichs GN; Frerichs CC
    Res Vet Sci; 1973 Mar; 14(2):187-93. PubMed ID: 4805140
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.